OMN-001
Mucopolysaccharidosis type I
PreclinicalActive
Key Facts
About Omnes Therapeutics
A Belgian AAV‑based gene‑therapy platform targeting rare metabolic diseases.
View full company profileMucopolysaccharidosis type I
A Belgian AAV‑based gene‑therapy platform targeting rare metabolic diseases.
View full company profile